Our built-in tools help you complete, sign, share, and store your documents in one place.
Make edits, fill in missing information, and update formatting in US Legal Forms—just like you would in MS Word.
Download a copy, print it, send it by email, or mail it via USPS—whatever works best for your next step.
Sign and collect signatures with our SignNow integration. Send to multiple recipients, set reminders, and more. Go Premium to unlock E-Sign.
If this form requires notarization, complete it online through a secure video call—no need to meet a notary in person or wait for an appointment.
We protect your documents and personal data by following strict security and privacy standards.

Make edits, fill in missing information, and update formatting in US Legal Forms—just like you would in MS Word.

Download a copy, print it, send it by email, or mail it via USPS—whatever works best for your next step.

Sign and collect signatures with our SignNow integration. Send to multiple recipients, set reminders, and more. Go Premium to unlock E-Sign.

If this form requires notarization, complete it online through a secure video call—no need to meet a notary in person or wait for an appointment.

We protect your documents and personal data by following strict security and privacy standards.
No, the use of an attorney or registered agent is not required for filing a patent application. However, an attorney or registered agent is often a useful resource and the USPTO recommends the use of such for preparing a patent application and conducting the proceedings in the USPTO.
Patent applications: the three criteria Novelty. This means that your invention must not have been made public – not even by yourself – before the date of the application. Inventive step. This means that your product or process must be an inventive solution. Industrial applicability.
A rejection on the ground of lack of utility is appropriate when (1) it is not apparent why the invention is “useful” because applicant has failed to identify any specific and substantial utility and there is no well established utility, or (2) an assertion of specific and substantial utility for the invention is not ...
Significant Stenosis Defined as. 75% or Greater Narrowing. The distribution of patients with no, one-, two- and. three-vessel and LMCA disease when significant.
These organizations suggest that stenoses above 50% should be graded within a range (i.e., 50–69% or 70% to near occlusion) to provide adequate information for clinical decision making.
A grade of patent without stenosis was given to any vessel displaying no or only minor disturbances in color-flow characteristics and no stenoses of ≥50%. A grade of patent with stenosis was assigned to any vessel displaying moderate or severe disturbances in color-flow characteristics and a stenosis of ≥50%.
The clinically important degree of stenosis is considered the percentage of stenosis that corresponds to a substantial increased risk for stroke. The USPSTF recommendations3 consider 60 to 99 percent stenosis to be clinically important.
Significant stenosis was defined as 50%or greater. Lesions in the anterolateral, posterior left ven- tricular and marginal branches of the three major cor- onary arteries were only defined as obstruction of their. associated major vessels if the branches were large.
Surgery is usually advised for carotid narrowing of more than 70%. Surgical treatment decreases the risk for stroke after symptoms such as TIA or minor stroke. Surgical treatment of carotid artery stenosis includes: Carotid endarterectomy (CEA).